glp-1 purpose Glucagon-like peptide-1 GLP-1 Receptor Agonists in Heart

arXiv preprint arXiv:2502.14239

They're generally at least somewhat effective, though the side effect profile may not be desirable to everyone

Participants with schizophrenia or schizoaffective disorder using this medication lost up to 5.3kg more of their starting weight and lowered their glucose levels (HbA1c) by 3.6 mmol/mol more after 6 months compared with participants taking placebo

Barreiro, E., Gea, J., Corominas, J

facility includes an in-house ICU, ACLS-certified nursing staff, and on-site emergency protocols ensuring patient safety at every treatment stage

Keeping oxidants down is perhaps the single most important thing you can do for vascular health